There are relevant studies on the use of hydroxychloroquine in the treatment of IgA nephropathy, but it has not been popularized in clinical work, so it is not possible to judge how effective it is.
There have been medical studies on the use of hydroxychloroquine in the treatment of IgA nephropathy in recent years, but the efficacy of this therapy has not yet been confirmed and popularized in clinical work, so it is not possible to judge how effective this drug is in treating IgA nephropathy.
IgA therapeutic drugs include angiotensin-converting enzyme inhibitors (e.g. Benadryl), angiotensin II receptor antagonists (e.g. Valsartan), hormones (Prednisone, Methylprednisolone), and other immunosuppressants (Cyclophosphamide, Azathioprine, Cyclosporine A, Mertiomercurial Phenolate, etc.).
Patients with IgA nephropathy should go to the hospital in time and use medication under the guidance of professional physicians.